Charles Burant appointed as Taubman Institute director

Diabetes and obesity researcher Charles Burant, M.D., Ph.D., has been named director of the A. Alfred Taubman Medical Research Institute at Michigan Medicine.

He succeeds Eva L. Feldman, M.D., Ph.D., who has served as director since the institute was founded in 2007 with a gift from the late philanthropist A. Alfred Taubman. Its mission is to enhance the support of physician-researchers at the University of Michigan through financial grants, mentoring programs and a collaborative community of Taubman Scholars.

“I’m thrilled to take the institute into its second decade,” said Burant. “I’m especially honored to be following my friend and mentor Eva Feldman in this position. As founding director of the institute, Dr. Feldman has built a world-class center that has helped multiple clinician-investigators in a critical stage of their careers, and led to discoveries that already are making a difference in people’s lives.

2017 Taubman Prize awarded to Stephen Hauser, MD

2017 Taubman Prize winner’s research led to new drug treatment for MS

Ann Arbor, Mich —  A physician-researcher whose work challenged conventional thinking about multiple sclerosis (MS) is the 2017 recipient of the $100,000 Taubman Prize for Excellence in Translational Medical Research, the A. Alfred Taubman Medical Research Institute announced.

Stephen L. Hauser, M.D., director of the UCSF Weill Institute for Neurosciences and professor and chair of the Department of Neurology at the University of California, San Francisco, will receive the honor in recognition of his paradigm-changing discoveries that paved the way for a highly effective drug in the treatment of MS.

Hauser will accept the award and deliver a keynote talk at the Taubman Institute’s annual symposium on October 20 in Ann Arbor.